Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled (High Dose) Immune Tolerance Induction (ITI)

NCT02207894 is registered in ClinicalTrials.gov with Haemophilia Centre Rhine Main as lead sponsor.

NCT NCT02207894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02207894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled (High Dose) Immune Tolerance Induction (ITI)
Lead sponsor
Haemophilia Centre Rhine Main
Phase
Observational
Overall status
Recruiting
Start date
August 31, 2006
Completion date
December 31, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilia a